Showing results (811-820 of 1,361) with videos related to
Sort By:
Pageof 137
Drugs Under Experimental and Clinical Research|October 15, 2005
Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%E Rallis, A Nasiopoulou, C Kouskoukis, et al.Drugs Under Experimental and Clinical Research|January 1, 1992
Ibuprofen inhibits adhesion-dependent neutrophil response by a glycoprotein-unrelated mechanismL Ottonello, G Pastorino, P Dapino, et al.Drugs Under Experimental and Clinical Research|January 1, 1992
Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogensG Blandino, F Caccamo, R Di Marco, et al.Drugs Under Experimental and Clinical Research|January 1, 1992
Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humansJ F Westphal, J M Brogard, F Jehl, et al.Drugs Under Experimental and Clinical Research|January 1, 1992
The action of propionyl-L-carnitine on the vasal endothelium: increased t-PA synthesis and a decrease in the activity of PAI-1. A preliminary studyP Pola, D De Martini, L Gerardino, et al.Drugs Under Experimental and Clinical Research|January 1, 1991
In vitro and in vivo antibacterial activities of ME1220 and ME1221, novel cephalosporinsR Okamoto, A Tamura, T Yoshida, et al.Drugs Under Experimental and Clinical Research|January 1, 1991
In vitro activity of cefsulodin against multi-resistant isolates of Pseudomonas aeruginosaS M Qadri, O Billington, B A CunhaDrugs Under Experimental and Clinical Research|January 1, 1991
Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometryK Shindo, Y HashimotoDrugs Under Experimental and Clinical Research|January 1, 1991
Release of platelet-activating factor (PAF) from human colon mucosa and its inhibition by 5-aminosalicylic acidF Capasso, I A Tavares, A BennettDrugs Under Experimental and Clinical Research|January 1, 1991
Treatment of lower respiratory infections in outpatients with ofloxacin compared with erythromycinR L Peugeot, B A Lipsky, T M Hooton, et al.Pageof 137